Functions of HLA-G in the immune system

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 150-152

  Favier, B ^a   LeMaoult, J ^a   Carosella, E D ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

HLA G; Immune inhibition; Tolerance

Indexed keywords

HLA G ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; CONFERENCE PAPER; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; PRIORITY JOURNAL;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE SYSTEM;

EID: 34247274772     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.763_6.x     Document Type: Conference Paper

References (29)

1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990: 248: 220-3.
2. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997: 186: 289-98.
3. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003: 64: 1039-44.
4. Ito T, Ito N, Saathoff M et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 2005: 125: 1139-48.
5. LeMaoult J, Le Discorde M, Rouas-Freiss N et al. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 2003: 62: 273-84.
6. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997: 94: 11520-5.
7. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 1997: 94: 5249-54.
8. Le Gal FA, Riteau B, Sedlik C et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999: 11: 1351-6.
9. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001: 33: 2355-9.
10. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001: 98: 12150-5.
11. Le Rond S, Azema C, Krawice-Radanne I et al. Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells. J Immunol 2006: 176: 3266-76.
12. Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999: 43: 203-11.
13. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004: 101: 7064-9.
14. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001: 13: 385-94.
15. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005: 35: 1133-42.
16. Colonna M, Navarro F, Bellon T et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997: 186: 1809-18.
17. Cosman D, Fanger N, Borges L et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997: 7: 273-82.
18. Saverino D, Fabbi M, Ghiotto F et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 2000: 165: 3742-55.
19. Colonna M, Samaridis J, Cella M et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998: 160: 3096-100.
20. Ponte M, Cantoni C, Biassoni R et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999: 96: 5674-9.
21. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999: 189: 1093-100.
22. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005: 19: 662-4.
23. Lozano JM, Gonzalez R, Kindelan JM et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002: 16: 347-51.
24. Cabello A, Rivero A, Garcia MJ et al. HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Hum Immunol 2003: 64: 1045-9.
25. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000: 164: 6426-34.
26. Paul P, Rouas-Freiss N, Khalil-Daher I et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998: 95: 4510-5.
27. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 2005: 65: 10139-44.
28. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000: 355: 2138.
29. Creput C, Durrbach A, Menier C et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003: 39: 587-94.